List of Figures:
Figure 3-1: Process of Viral Replication
Figure 3-2: RNAi Action Mechanism
Figure 3-3: Processing of dsRNA & shRNA
Figure 4-1: Global - RNAi Market (Billion US$), 2011 & 2015
List of Tables:
Table 5-1: Advantages of RNAi Therapies over Conventional Drugs
Table 6-1: Pipeline RNAi Drugs for Oncology
Table 6-2: Pipeline RNAi Drugs for Ocular and Retinal Disorders
Table 6-3: Prevalence Statistics of Viral Infections
Table 6-4: Pipeline RNAi Drugs for Viral Infections
Table 7-1: RNAi Inhibitors Products of Key Companies
Table 7-2: RNAi Library Products of Key Companies
Table 7-3: RNAi Reagent Products of Key Companies
Table 7-4: RNAi Vector Products of Key Companies
Table 7-5: RNAi Assays Products of Key Companies
Table 7-6: RNAi Control Products of Key Companies
Table 7-7: RNAi Mimic Products of Key Companies
Table 7-8: RNAi Services of Key Companies
Table 8-1: Pipeline RNAi Drugs of Key Companies by Phase
Table 10-1: Alnylam - Key RNAi Products in Pipeline
Table 10-2: Benitec - Key RNAi Products in Pipeline
Table 10-3: Bioneer Corporation - Key RNai Products
Table 10-4: Calando Pharmaceuticals - Key RNAi Products in Pipeline
Table 10-5: Dharmacon - Key RNAi Products
Table 10-6: Galena Pharmaceuticals (RXi) - Key RNAi Products in Pipeline
Table 10-7: Integrated DNA Technologies - Key RNAi Products
Table 10-8: Life Technologies Corporation - Key RNAi Products
Table 10-9: Qiagen - Key RNAi Products
Table 10-10: Quark Pharmaceuticals - Key RNAi Products in Pipeline
Table 10-11: Sigma-Aldrich Corporation - Key RNAi Products
Table 10-12: Silence Therapeutics - Key RNAi Products
Table 10-13: Silence Therapeutics - Key RNAi Products in Pipeline
Table 10-14: Tekmira Pharmaceuticals - Key RNAi Products in Pipeline
